PIMPINELLI, NICOLA
 Distribuzione geografica
Continente #
EU - Europa 18.857
NA - Nord America 13.953
AS - Asia 5.550
SA - Sud America 859
AF - Africa 197
OC - Oceania 141
Continente sconosciuto - Info sul continente non disponibili 2
Totale 39.559
Nazione #
US - Stati Uniti d'America 13.839
PL - Polonia 11.177
RU - Federazione Russa 3.309
SG - Singapore 1.591
CN - Cina 1.194
IT - Italia 1.073
HK - Hong Kong 981
IE - Irlanda 863
SE - Svezia 752
BR - Brasile 703
KR - Corea 578
VN - Vietnam 416
DE - Germania 412
UA - Ucraina 373
FI - Finlandia 301
GB - Regno Unito 229
IN - India 210
JO - Giordania 179
AU - Australia 136
ID - Indonesia 135
FR - Francia 123
CH - Svizzera 98
CI - Costa d'Avorio 87
TR - Turchia 78
CA - Canada 73
AR - Argentina 62
EC - Ecuador 39
NL - Olanda 38
ZA - Sudafrica 36
BD - Bangladesh 31
JP - Giappone 31
ES - Italia 29
MX - Messico 27
IQ - Iraq 26
BE - Belgio 17
SC - Seychelles 17
AT - Austria 16
CL - Cile 16
MA - Marocco 15
UZ - Uzbekistan 15
PK - Pakistan 13
PY - Paraguay 12
VE - Venezuela 11
TN - Tunisia 10
AE - Emirati Arabi Uniti 9
CZ - Repubblica Ceca 9
IL - Israele 7
KE - Kenya 7
LT - Lituania 7
PH - Filippine 7
CO - Colombia 6
RO - Romania 6
SA - Arabia Saudita 6
DO - Repubblica Dominicana 5
EG - Egitto 5
KG - Kirghizistan 5
SN - Senegal 5
IR - Iran 4
JM - Giamaica 4
KZ - Kazakistan 4
NZ - Nuova Zelanda 4
UY - Uruguay 4
AL - Albania 3
AZ - Azerbaigian 3
BJ - Benin 3
DZ - Algeria 3
ET - Etiopia 3
GR - Grecia 3
KW - Kuwait 3
MD - Moldavia 3
MY - Malesia 3
PE - Perù 3
PS - Palestinian Territory 3
AM - Armenia 2
BH - Bahrain 2
BO - Bolivia 2
BY - Bielorussia 2
EU - Europa 2
GE - Georgia 2
HN - Honduras 2
HU - Ungheria 2
LV - Lettonia 2
NO - Norvegia 2
NP - Nepal 2
SM - San Marino 2
TH - Thailandia 2
TW - Taiwan 2
BF - Burkina Faso 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BW - Botswana 1
CM - Camerun 1
CR - Costa Rica 1
DK - Danimarca 1
GT - Guatemala 1
KH - Cambogia 1
LU - Lussemburgo 1
MG - Madagascar 1
MN - Mongolia 1
NG - Nigeria 1
Totale 39.549
Città #
Warsaw 11.169
Santa Clara 3.029
Fairfield 1.289
Ashburn 1.110
Singapore 1.027
Dublin 862
Chandler 839
Hong Kong 780
Seoul 560
Cambridge 557
Jacksonville 548
Woodbridge 545
Seattle 497
Houston 470
Wilmington 443
Beijing 358
Hefei 262
Princeton 232
Buffalo 230
Ann Arbor 215
Boston 182
Lawrence 180
Altamura 179
Florence 179
Boardman 159
San Jose 152
Mumbai 148
Los Angeles 142
Melbourne 134
Dong Ket 115
The Dalles 113
Jakarta 108
Medford 108
Moscow 106
San Diego 100
Council Bluffs 92
Ho Chi Minh City 92
New York 91
Abidjan 87
Bern 86
Dallas 86
Helsinki 76
Phoenix 66
Kent 59
Shanghai 58
Hanoi 57
Munich 57
São Paulo 56
Milan 55
Paris 53
Rome 49
Izmir 46
London 39
Norwalk 39
Redondo Beach 37
Chicago 35
West Jordan 30
Rio de Janeiro 26
Bremen 25
Falls Church 25
Hillsboro 25
Toronto 24
Brooklyn 23
Tokyo 23
Belo Horizonte 22
Frankfurt Am Main 22
Frankfurt am Main 22
Tianjin 21
Andover 19
Clifton 19
Turku 18
Verona 18
Johannesburg 17
Brussels 16
Denver 16
Montreal 15
Pune 15
Quito 15
Washington 15
Yubileyny 15
Auburn Hills 14
Atlanta 13
Poplar 13
Seongnam 13
Stockholm 13
Chennai 12
Laurel 12
Tashkent 12
Guayaquil 11
Amman 10
Ankara 10
Baghdad 10
Da Nang 10
Dearborn 10
Haiphong 10
Miami 10
Prato 10
Amsterdam 9
Bengaluru 9
Biên Hòa 9
Totale 29.149
Nome #
Lesioni cutanee «specifiche» in corso di leucemia linfatica cronica. 551
Defining early mycosis fungoides. 374
B-cell lymphoma with secondary cutaneous involvement: an immunohistochemical and ultrastructural study 357
Familial and sporadic melanoma: different clinical and histopathological features in the Italian population - a multicentre epidemiological study - by GIPMe (Italian Multidisciplinary Group on Melanoma). 321
CD30+ cutaneous T-cell lymphoma associated with sarcoidosis 319
BCA-1, A B-cell chemoattractant signal, is constantly expressed in cutaneous lymphoproliferative B-cell disorders. 317
Immunophenotypical markers, ultrastructure and chemosensitivity profile of metastatic melanoma cells. 314
IMMUNOHISTOCHEMICAL EVIDENCE OF SKIN IMMUNE SYSTEM INVOLVEMENT IN VULVAR LICHEN SCLEROSUS ET ATROPHICUS 306
Atypical CD30+ cutaneous lymphoid proliferation in a patient with tuberculosis infection. 306
Early apoptosis plays an important role in the healing mechanism of cutaneous basal cell carcinomas after photodynamic therapy 300
Control of the differentiation state and function of human epidermal Langerhans cells by cytokines in vitro 298
CD30-CD30 ligand interaction in primary cutaneous CD30+ T-cell lymphomas: a clue to pathophysiology of clinical regression. 298
Cutaneous lymphoma: A clinically relevant classification 297
Dendritic cells: ultrastructural and immunophenotypical changes upon nb-UVB in vitiligo skin. 295
Skin cancer and immunosuppression 295
Inhibition of uPAR-TGFβ crosstalk blocks MSC-dependent EMT in melanoma cells 293
CD36(OKM5)+ dendritic cells in the oral mucosa of HIV- and HIV+ subjects 291
LANGERHANS CELLS AND MYCOSIS FUNGOIDES-A CRITICAL OVERVIEW OF THEIR PATHOGENIC ROLE IN THE DISEASE 290
HEDGEHOG-GLI Signaling Drives Self-Renewal and Tumorigenicity of Human Melanoma-Initiating Cells. 290
Massive recruitment of type I interferon producing plasmacytoid dendritic cells in varicella skin lesions. 289
Antigenic phenotype of radial growth phase melanomas with or without a vertical growth phase portion. 288
A peculiar case of linear IgA bullous dermatosis. 287
Primary cutaneous follicular centre- cell lymphoma- a lymphoproliferative disease with favourable prognosis. 287
Dendritic cells in T- and B-cell proliferation in the skin 286
Primary cutaneous B-cell lymphoma: A clinically homogeneous entity? 284
Practice guidelines for the management of extranodal non-Hodgkin's lymphomas of adult non-immunodeficient patients. Part I: primary lung and mediastinal lymphomas. A project of the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation. 279
Monochromatic excimer light (308 nm) in patch-stage IA mycosis fungoides. 277
Morphology and membrane antigens of non-lymphoid accessory cells in oral hairy leukoplakia 276
LANGERHANS CELLS AND EPIDERMAL MICROENVIRONMENT 275
Please, sir, pull down your socks! 275
MASKED CUTANEOUS LEISHMANIASIS 274
SCLEROSING EPITHELIAL HAMARTOMA ASSOCIATED WITH A MELANOCYTIC COMPOUND NEVUS 269
STEM CELL FACTOR AFFECTS TUMOUR PROGRESSION MARKERS IN METASTATIC MELANOMA CEELS 269
Hepatitis C virus:a common triggering factor for both nodular vasculitis and Sjogren's syndrome? 267
Dendritic cells in the skin after allogeneic bone marrow transplantation: immunohistochemical and electron microscopic monitoring 265
Cutaneous B-cell lymphomas: facts and open issues. 263
Topical photodynamic therapy for primary cutaneous B-cell lymphoma: a pilot study. 263
Serial QuantiFERON TB-Gold in-tube testing during LTBI therapy in candidates for TNFi treatment 262
EGFR/uPAR interaction as druggable target to overcome vemurafenib acquired resistance in melanoma cells 259
THE SKIN-ASSOCIATED LYMPHOID TISSUE-RELATED B-CELL LYMPHOMAS 258
[Significance and possible role of reactive T-cell infiltrate in primary B-cell lymphoma of the skin]. 257
Wide-area 308-nm phototherapy with nonlaser light in the treatment of psoriasis: results of a pilot study. 255
Dendritic cells in cutaneous lupus erythematosus: a hint to the pathogenesis of lesions 255
Classic and immunodeficiency-associated Kaposi's sarcoma. Clinical, histologic and immunologic correlations. 254
Non-lymphoid accessory cells in the cutaneous infiltrate of B cell lymphomas. An immunohistochemical and ultrastructural study 253
SPECIFIC IMMUNE THERAPY-RELATED CUTANEOUS b-CELL PSEUDOLYMPHOMA WITH FOLLOWING DISSEMINATION 252
Dendritic cells recruitment in melanoma metastasis treated by electrochemotherapy. 252
Interdigitating reticulum cells in the dermal infiltrate of mycosis fungoides. An ultrastructural and immunohistochemical study. 251
WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects 251
Plaque-type parapsoriasis and mycosis fungoides: An unclear relationship 250
Plasmacytoid dendritic cells represent a major dendritic cell subset in sentinel lymph nodes of melanoma patients and accumulate in metastatic nodes. 250
CULTURED EPIDERMIS IN THE TREATMENT OF LEG ULCER:EDGE EFFECT AND CORRELATION WITH KERATINOCYTE PROLIFERATION INDEX 250
Primary cutaneous B-cell lymphoma: A unique type of low grade lymphoma. Clinicopathologic and immunologic study of 83 cases 249
New aspects in the biology of cutaneous B-cell lymphomas. 249
BILATERAL CHONDROMA OF THE AURICLE 249
EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma. 249
Evaluation of efficacy of a skin lipid mixture in patients with irritant contact dermatitis, allergic contact dermatitis or atopic dermatitis: a multicenter study. 247
Multiple marker studies on a malignant fibrous hystiocytoma with primary cutaneous localization. 246
Primary cutaneous B-cell lymphomas. Current concepts. I. 242
Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer. 241
SCLEROSING EPITHELIAL HAMARTOMA:A TYPICAL PICTURE,A NAME THAT CAUSES DEBATE 241
Expression and prognostic significance of matrix metalloproteinases and their tissue inhibitors in primary neuroendocrine carcinoma of the skin. 239
THE TREATMENT OF BASAL CELL CARCINOMAS IN A PATIENT WITH XERODERMA PIGMENTOSUM WITH A COMBINATION OF IMIQUIMOD 5% CREAM AND ORAL ACITREIN 238
Human Langerhans cells are immature in melanoma sentinel lymph nodes. 237
CYTOTOXIC/NATURAL KILLER CELL CUTANEOUS LYMPHOMAS: REPORT OF THE E.O.R.T.C. CUTANEOUS LYMPHOMA TASK FORCE WORKSHOP. 236
Pegylated liposomal doxorubicin in the treatment of primary cutaneous T-cell lymphomas. 234
Efficacy and safety of pegylated liposomal doxorubicin in primary cutaneous B-cell lymphomas and comparison with the commonly used therapies. 232
Immunoglobulin heavy chain variable region family expression in primary cutaneous follicle centre cell lymphomas. 231
Increase in FOXP3(+) Regulatory T Cells in GVHD Skin Biopsies Is Associated with Lower Disease Severity and Treatment Response 231
Stevens-Johnson syndrome induced by Vaxvetria (AZD1222) COVID-19 vaccine 229
Localized scleroderma-like lesions in autologous bone marrow transplantation. 229
Immunohistological features of genital warts before and after intralesional human lymphoblastoid alpha-interferon: evidence for a substancial role of cell-mediated immunity in clinical regression 228
Granular IgA deposits in the skin of patients with Coeliac disease: Is it always dermatitis herpetiformis? 228
Primary cutaneous CD30+ T-cell lymphomas: hypothesis for a highly distinctive clinicobiological behaviour. 226
TOPICAL CORTICOSTEROIDS.WHICH DRUG AND WHEN? 224
Time course, clinical pathways, and long-term hazards risk trends of disease progression in patients with classic mycosis fungoides: A multicenter, retrospective follow-up study from the Italian Group of Cutaneous Lymphomas. 224
Relationship between Latitude and Melanoma in Italy. 223
Conversion from calcineurin inhibitors to everolimus with low-dose cyclosporine in renal transplant recipients with squamous cell carcinoma of the skin. 221
The New Faces of Cutaneous Lymphoma 219
Interessamento cutaneo in corso di leucemia mielo-monocitica 218
The burden of cutaneous adnexal carcinomas and the risk of associated squamous cell carcinoma: a population-based study 216
Melanoma cell therapy: Endothelial progenitor cells as shuttle of the MMP12 uPAR-degrading enzyme 215
ALA-PDT exerts beneficial effects on chronic venous ulcers by inducing changes in inflammatory microenvironment, especially through increased TGF-beta release: a pilot clinical and translational study 213
EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome. 210
Immunophenotypic analysis of normal human dendritic cells isolated from epidermis and dermis 210
Cellule di Sézary: attività immunologiche " in vitro" ed effetto della timostimulina 208
Features and differentiation of dendritic cells in cutaneous lupus erythematosus 206
Lamina propria dendritic cells express activation markers and contact lymphocytes in chronic adult periodontitis 203
A key role for poly(ADP-ribose) polymerase-1 activity during human dendritic cell maturation. 200
Eosinophilic dermatosis of hematologic malignancy: A retrospective cohort of 37 patients from an Italian center 198
Gemcitabine as frontline treatment for cutaneous T-cell lymphoma: phase II study of 32 patients. 198
Architectural and antigenic features of follicular dendritic cells as a clue to the histogenesis of primary cutaneous B-cell lymphoma 194
Neuroimmunomodulation in chronic wounds healing after treatment with photodynamic therapy: the Role of iNOS. 193
Indoleamine 2,3-dioxygenase+ cells correspond to the BDCA2+ plasmacytoid dendritic cells in human melanoma sentinel nodes 192
CD63 Tetraspanin Is a Negative Driver of Epithelial-to-Mesenchymal Transition in Human Melanoma Cells 190
ROLE OF CONVENTIONAL TREATMENTS ON CIRCULATING AND MONOCYTE-DERIVED DENDRITIC CELLS IN COLORECTAL CANCER 183
Clindamycin as unique antibiotic choice in Hidradenitis Suppurativa 180
Primary cutaneous CD8+ CD30+ lymphoproliferative disorder in a patient with acquired CD4 immunodeficiency 176
Fatal occurrence of acquired haemophilia A in a patient with pemphigus vulgaris 171
Endocrine toxicity in cancer patients treated with nivolumab or pembrolizumab: results of a large multicentre study. 170
Totale 25.380
Categoria #
all - tutte 91.817
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.817


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.931 0 0 0 0 0 0 218 342 342 596 139 294
2021/20221.523 48 161 69 55 49 101 62 99 65 105 270 439
2022/20233.968 410 525 173 265 348 680 493 198 509 70 170 127
2023/20241.458 68 166 265 84 99 176 105 238 24 94 87 52
2024/20259.113 343 1.014 653 1.329 2.754 1.114 138 399 495 261 352 261
2025/20265.844 1.050 1.452 803 720 1.107 425 287 0 0 0 0 0
Totale 39.722